Target intelligence / Profile preview

MicroRNA 575 (MIR575)

Target
MIR575
Molecular classification
microRNA (miRNA), Non-coding RNA
01

Overview

MicroRNA 575 (MIR575) is a small, non-coding RNA (miRNA) found in humans that regulates gene expression at the post-transcriptional level by binding to the 3′ untranslated regions of target mRNAs, thus influencing mRNA stability and translation. MIR575 is involved in various cellular processes including proliferation, migration, and apoptosis, and acts as an oncogene in several cancers by targeting genes such as PTEN and BLID. It is also associated with diseases such as lupus nephritis and arrhythmogenic right ventricular cardiomyopathy. MIR575 is considered a promising therapeutic target and biomarker in oncology, although miRNA-targeted drugs are still largely in development. Therapeutic interventions targeting MIR575 must be carefully designed to avoid unintended systemic effects due to the widespread regulatory influence of miRNAs.

Other names
MIR575hsa-mir-575MIRN575microRNA 575
02

Mechanism of action

Drugs or molecules interfering with MIR575 would likely act by antisense inhibition (anti-miR), sponging, or modulation of regulatory networks affected by its targets (such as PTEN, BLID)

03

Biological functions

Post-transcriptional regulation of gene expressionCellular development and differentiationCell proliferation and migrationApoptosis regulationRegulation of immune response
04

Disease associations

Cancer (e.g., gastric cancer, glioblastoma, non-small cell lung cancer)Lupus nephritis (autoimmune disease)Arrhythmogenic right ventricular cardiomyopathy (cardiac disease)
05

Safety considerations

Therapeutic modulation of microRNAs poses risks of off-target effects and global changes in gene expression, impacting cellular homeostasisImmune and oncogenic effects due to alteration of pathways regulated by MIR575
06

Interacting drugs

No specific drugs targeting MIR575 are cited in current literature or databases. MicroRNA-targeting therapeutics are generally experimental and few are in clinical use
07

Biomarkers

MIR575, and its regulated pathways (e.g., PTEN, BLID) are explored as potential prognostic biomarkers in cancer (e.g., gastric cancer prognosis)

Beyond the preview

Go deeper on MicroRNA 575 (MIR575).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 575 (MIR575).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call